C12N 2770/28134
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2770/28134 (Use of virus or viral component as vaccine) appears on 17 US grants and 26 published applications in this corpus.
Search patents in C12N- Granted patents
- 17
- Published applications
- 26
- Assignees
- 19
- Inventors
- 46
- Latest grant
- 3 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 1 | 3 |
| 2011 | 0 | 1 |
| 2012 | 0 | 3 |
| 2013 | 1 | 1 |
| 2014 | 4 | 2 |
| 2015 | 1 | 1 |
| 2016 | 2 | 5 |
| 2017 | 4 | 2 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Norovirus S particle based vaccines and methods of making and using same3 Feb 2026US 12,539,327 B2Children's Hospital Medical Center
- Norovirus S particle based vaccines and methods of making and using same5 Dec 2023US 11,833,198 B2Children's Hospital Medical Center
- Vaccine combinations28 Aug 2018US 10,058,605 B2Bharat Biotech International Limited
- Infectious hepatitis E virus genotype 3 recombinants26 Dec 2017US 9,850,468 B2Royal Cornwall Hospital Trust
- Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof19 Sep 2017US 9,764,028 B2Xiamen Innovax Biotech Co., Ltd.
- A Fusion Protein and a Particulate Antigen Containing the Same27 Aug 2026US 2026/0250328 A1Xiamen Innovax Biotech Co., Ltd.
- Virus-like nanocapsid for oral delivery of insulin11 Jun 2026US 2026/0159817 A1The Regents of the University of California
- Norovirus s particle based vaccines and methods of making and using same26 Sep 2024US 2024/0316176 A1Children's Hospital Medical Center
- Virus-like nanocapsid for oral delivery of insulin11 Feb 2021US 2021/0038697 A1The Regents of the University of California
- Norovirus s particle based vaccines and methods of making and using same5 Mar 2020US 2020/0069787 A1Children's Hospital Medical Center
Most cited
By later US patents
- Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector4US 8,906,863 B2The Regents of the University of California · 2014
- Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof2US 7,786,264 B2Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. · 2010
- Multiple antigen delivery system using hepatitis E virus-like particle2US 8,906,862 B2National Institute of Infectious Disease · 2014
- Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof2US 9,512,185 B2Xiamen Innovax Biotech Co., Ltd. · 2016
- Norovirus S particle based vaccines and methods of making and using same1US 11,833,198 B2Children's Hospital Medical Center · 2023